| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6247e883af718dbaced23561e1d701dd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e6793134fe291272e4c4614972e3ae04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_58395e1559397986b564669884336661
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d121b8ef864cae4556f46805d20bc3d1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_10e4b1416c6e66e0ade5429212414964 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C2601-14 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C217-74
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C215-42
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C213-10 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C213-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C215-42
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C209-84
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-137
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C217-74
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C217-60
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C213-08 |
| filingDate |
2001-10-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b3f6f9c8d19d8312b46707261d29c0a6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_16a12236b23d22bcd087ccdf881adf4b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2908cda57e8ee8156cd2a5545087e5dd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f2c8360dc9042ae48c7896d5cc245929 |
| publicationDate |
2003-01-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-0245658-A3 |
| titleOfInvention |
Crystalline venlafaxine base and novel polymorphs of venlafaxine hydrochloride, processes for preparing thereof |
| abstract |
The present invention relates to novel essentially pure venlafaxine and the process of preparation thereof. The present invention also relates to novel solvate forms of venlafaxine hydrochloride and the process of preparation thereof. Furthermore, the present invention provides a novel process for preparing venlafaxine hydrochloride from venlafaxine; the process comprises the steps of: i) preparing a mixture of venlafaxine with acetone; and ii) exposing the mixture in gaseous hydrochoric acid. |
| priorityDate |
2000-10-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |